Has Tajuana Bradley received payments from drug or device companies?

Yes. Drug and device makers reported $255,505 in general payments to Tajuana Bradley across 583 transactions between 2019–2025. Most Open Payments records nationally are meals worth under $20; a reported payment is not evidence of wrongdoing.

Does a payment mean Tajuana Bradley did something wrong?

No. Federal law requires drug and device makers to report almost every transfer of value to a physician, including a $14 sandwich at a lunch presentation. Consulting fees, research funding and royalties to device inventors are ordinary, legal parts of medicine. This site reports what was disclosed; it makes no allegation.

Where does this information about Tajuana Bradley come from?

The U.S. Centers for Medicare & Medicaid Services. Payments come from Open Payments, published under the Physician Payments Sunshine Act. Billing and prescribing figures come from the Medicare Physician & Other Practitioners and Part D Prescriber public use files for 2024.

Tajuana Bradley

Nurse Practitioner · Johns Creek, GANPI 1215266358

Payments from drug & device makers

$255,505in general payments, 2019–2025

Across 583 payments — averaging $438.26 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

AstraZeneca$90K
Daiichi Sankyo Inc.$76K
Seagen Inc.$14K
E.r. Squibb & Sons, L.L.C.$14K
Geron Corporation$9K
G1 Therapeutics, Inc.$8K
plus $45K from 53 others

What the payments were for

Consulting fees$22,2049%
Speaking & faculty fees$182,48571%
Travel & lodging$34,52914%
Food & beverage$16,1096%
Education$1790%

General payments by program year

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

Company	Payments	Total
AstraZeneca(2 entities)	155	$90,125
Daiichi Sankyo Inc.	120	$76,191
Seagen Inc.	43	$14,089
E.r. Squibb & Sons, L.L.C.	27	$13,960
Geron Corporation	7	$8,558
G1 Therapeutics, Inc.	13	$7,720
CTI Biopharma Corp.	17	$6,190
GSK	11	$6,118
Gilead	20	$5,933
Sobi, Inc	8	$5,151
Puma Biotechnology, Inc.	6	$3,022
Incyte Corporation	19	$2,792
Coherus Oncology, Inc.	4	$2,395
ADC Therapeutics America, Inc.	8	$1,901
Bristol Myers Squibb	16	$1,835
Takeda Pharmaceuticals U.S.A., Inc.	2	$1,423
Amgen	3	$879
Astrazeneca UK Limited	1	$875
Janssen Scientific Affairs, LLC	2	$843
Stemline Therapeutics Inc.	2	$809
Epizyme, Inc.	1	$495
Johnson & Johnson	7	$430
Novartis	10	$328
Karyopharm Therapeutics Inc.	3	$314
AbbVie	7	$276
Eisai Inc.	4	$177
Adaptive Biotechnologies Corporation	4	$167
Scpharmaceuticals Inc.	1	$150
Pharmacyclics LLC, An Abbvie Company	2	$142
Sanofi	5	$142
Morphosys, US Inc.	1	$140
Exelixis Inc.	3	$138
Immunogen, Inc.	2	$133
Neurocrine Biosciences, Inc.	1	$133
Jazz Pharmaceuticals Inc.	5	$130
Regeneron Healthcare Solutions, Inc.	1	$124
Bayer	6	$121
Pfizer	6	$121
Secura Bio, Inc.	1	$112
Beone Medicines USA, Inc.	4	$109
Medtronic	1	$98
Syndax Pharmaceuticals, Inc.	1	$94
Ipsen Biopharmaceuticals, Inc	1	$91
Beigene USA, Inc.	3	$68
Pharmaessentia USA Corporation	2	$60
Boehringer Ingelheim	2	$55
Rigel Pharmaceuticals, Inc.	2	$42
Lilly USA, LLC	2	$38
EMD Serono, Inc.	1	$38
Tersera Therapeutics LLC	1	$36
Taiho Oncology, Inc.	1	$30
Genentech USA, Inc.	1	$29
Acrotech Biopharma Inc.	1	$27
Caris MPI, Inc.	1	$21
Deciphera Pharmaceuticals Inc.	1	$20
Myovant Sciences Inc.	1	$19
Teva Pharmaceuticals USA, Inc.	1	$18
Apellis Pharmaceuticals, Inc.	1	$17
Array Biopharma Inc	1	$15

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

Enhertu$88,160
LYNPARZA$31,384
CALQUENCE$21,700
Vonjo$10,810
OPDIVO$8,475
RYTELO$8,376
COSELA$7,625
DATROWAY$7,194
TUKYSA$6,713
ADCETRIS$6,613
Trodelvy$5,177
OJJAARA$5,134
Nerlynx$3,000
Udenyca$2,255
IMFINZI$1,350
IMBRUVICA$1,015
Orserdu$735
Yescarta$263
XPOVIO$245
Copiktra$223

How this compares

$255,505 in reported general payments places this provider in the 95th percentile of 3,328 nurse practitioner providers in Georgia.

See all nurse practitioner providers in Georgia →

Medicare billing

Part B allowed, 2024

$12,190

Medicare patients

111

Services billed

234

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Other nurse practitioner in Johns Creek

Meredith KirkJohns Creek$13K
Jacqueline RichartJohns Creek$11K
Crystal LogsdonSavannah$566K
Victor CzerkasijDalton$505K
Kennon Mc CollumStockbridge$364K
Pamela AllenRome$270K
Janice McAlisterAtlanta$241K
Jessica AdkinsSavannah$226K
Laura ElledgeAtlanta$177K
Afsha HussainiKennesaw$122K

See the full list for Georgia →

Where these figures come from

Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
Identity: NPPES NPI Registry, July 2026.

Is this you, or does something look wrong? →